Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Lanshan (Beijing) Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Lanshan (Beijing) Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lanshan (Beijing) Biotechnology
Developer of innovative biological products designed to advance medical research and therapeutic development. The company offers cutting-edge biotechnological tools and proprietary formulations, enabling pharmaceutical and research institutions to enhance experimental accuracy and accelerate drug discovery.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Lanshan (Beijing) Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lanshan (Beijing) Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lanshan (Beijing) Biotechnology in its N-PORT filings yet. We sweep new filings monthly.